Matthew Ira Lockhart, APRN

Matthew Lockhart practices at First Physicians Group in Nokomis, Florida.

Matthew Lockhart's NPI, 1609503275, was assigned on August 4, 2022. Matthew Lockhart holds Florida license APRN11020346.

Matthew Lockhart's primary practice is First Physicians Group, at 200 Healthcare Way, Nokomis, FL 34275 in Sarasota County. The practice phone is (941) 917-8720.

Matthew Lockhart's primary practice is First Physicians Group in Nokomis, Florida. Matthew Lockhart is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is First Physicians Group of Sarasota. Dmand AI also links Matthew Lockhart to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Lockhart practices, 4 sites in all. Vendor and product names are available with a free account.

Family is Matthew Lockhart's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Matthew Lockhart is licensed in Florida.

Dmand AI lists chronic diabetes, chronic kidney disease, high cholesterol and tobacco use among the conditions Matthew Lockhart treats.

CMS data shows 153 Medicare services from Matthew Lockhart across 2 procedure codes in 2024, for 122 Medicare patients. Medicare paid $9,449 for them. Every service was in an office.

CMS counts 122 Medicare patients who saw Matthew Lockhart in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Matthew Lockhart's median patient age at 76, with 44% women.

In 2024, Matthew Lockhart wrote 1,188 Medicare Part D claims for 399 patients. 84% of them were for generic drugs. CMS names the drug for 1,007 of them, across 24 drugs with 11 or more claims each, at $191,700 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Matthew Lockhart for performance year 2024, reported as part of a group. Matthew Lockhart accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 25 general payments to Matthew Lockhart from 10 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $364.